CVE-2024-12014
Description
Path Traversal vulnerability in the eSignaViewer component in eSigna product versions 1.0 to 1.5 on all platforms allow an unauthenticated attacker to access arbitrary files in the document system via manipulation of file paths and object identifiers.
AI Insight
LLM-synthesized narrative grounded in this CVE's description and references.
Path traversal and IDOR vulnerabilities in eSignaViewer allow unauthenticated attackers to access arbitrary files via manipulated file paths and object identifiers.
Vulnerability
Overview CVE-2024-12014 is a path traversal and Insecure Direct Object Reference (IDOR) vulnerability in the eSignaViewer component of eSigna product versions 1.0 to 1.5. The root cause is improper implementation of security controls, allowing attackers to manipulate file paths and object identifiers such as document IDs [1].
Exploitation
An unauthenticated attacker can exploit this flaw by crafting malicious file paths to traverse directories and access restricted files, or by modifying object references to bypass authorization checks. The attack requires network access to the eSignaViewer component; no authentication is needed [1].
Impact
Successful exploitation can lead to unauthorized access to sensitive files, potentially resulting in data exposure and regulatory violations. However, the advisory notes that the overall impact is considered low [1].
Mitigation
Lleidanet PKI SL has released patched versions of eSignaViewer that implement stronger input validation and authorization controls. Users are advised to upgrade to the latest version and adopt complementary measures such as logging suspicious activities and performing regular security audits [1].
AI Insight generated on May 20, 2026. Synthesized from this CVE's description and the cited reference URLs; citations are validated against the source bundle.
Patches
0No patches discovered yet.
Vulnerability mechanics
AI mechanics synthesis has not run for this CVE yet.
References
1News mentions
0No linked articles in our index yet.